Fingerprint
Dive into the research topics of 'Phase II study of high‐dose tamoxifen (NSC‐180973) in patients with disseminated malignant melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of high‐dose tamoxifen (NSC‐180973) in patients with disseminated malignant melanoma
Edward T. Creagan, James N. Ingle, David L. Ahmann, Stephanie J. Green
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations